Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
COMPLETED
NCT03267732
PHASE1
A Study to Evaluate the Pharmacokinetics in Participants After Dosing With Pegilodecakin (LY3500518)
Sponsor: Eli Lilly and Company
View on ClinicalTrials.gov
Summary
To evaluate the pharmacokinetics of single and multiple doses of pegilodecakin in healthy participants.
Official title: A Phase 1 Study to Evaluate the Pharmacokinetics of Single and Multiple Doses of AM0010 in Healthy Adult Subjects
Key Details
Gender
All
Age Range
18 Years - 55 Years
Study Type
INTERVENTIONAL
Enrollment
24
Start Date
2017-09-05
Completion Date
2017-10-17
Last Updated
2026-10-02
Healthy Volunteers
Yes
Conditions
Interventions
BIOLOGICAL
Pegilodecakin
Administered SQ
Locations (1)
PPD Development
Austin, Texas, United States